Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's Largest Private Drug Distributor, Jointown, Seeks Initial Public Offering In Shanghai

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - To compete with the country's largest drug distributor SinoPharm, China's third-ranked Jointown recently filed for an initial public offering in Shanghai to raise roughly RMB 899.8 million ($135.4 million) to expand a distribution network in seven key regions across China
Advertisement

Related Content

Pfizer Looks To Team Up With Shanghai Pharmaceutical To Co-develop And Commercialize Pfizer Products In China
Pfizer Looks To Team Up With Shanghai Pharmaceutical To Co-develop And Commercialize Pfizer Products In China
Cardinal Health's Acquisition Of Zuellig Pharma Signal Of China's Intent To Allow More Foreign Investment?
Does Cardinal Health's Acquisition Of Zuellig Pharma Signal China's Intent To Allow More Foreign Investment?
Sihuan Pharma Trades At 28 Percent Above IPO Target; Analysts Point To Risks
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2010
Sihuan Pharmaceuticals Hong Kong IPO Draws Major Cornerstone Investors
Global Pharmaceutical Sales Expected To Reach $880 Billion In 2011 With China Fueling Growth
Global Pharmaceutical Sales Expected To Reach $880 Billion In 2011 With China Fueling Growth
China's New Drug Price Policies Will Favor Big Distributors, Restrict Smaller Ones
Advertisement
UsernamePublicRestriction

Register

SC073323

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel